Successful treatment of refractory lung adenocarcinoma harboring a germline BRCA2 mutation with olaparib: A case report

BACKGROUND: In recent years, targeted therapy and immunotherapy have become important treatment strategies for patients with non-small cell lung cancer (NSCLC). However, the clinical evidence for successful off-label use of targeted drugs for patients with NSCLC following progression on multiple lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Wang, Jing, Cui, Ling-Zhi, Wang, Kai, Yuan, Ming-Ming, Chen, Rong-Rong, Zhang, Li-Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464460/
https://www.ncbi.nlm.nih.gov/pubmed/34616818
http://dx.doi.org/10.12998/wjcc.v9.i25.7498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464460/
https://www.ncbi.nlm.nih.gov/pubmed/34616818
http://dx.doi.org/10.12998/wjcc.v9.i25.7498

Ejemplares similares